Advertisement
Table 1 Statistical analysis of the subjects by their LGV status
| LGV negative | LGV positive | P value | |
|---|---|---|---|
| N = 95 | N = 13 | ||
| Reported symptoms % (n) | 20% (19) | 100% (13) | <0.001 |
| MSM % (n) | 91.6% (87) | 100% (13) | 0.601 |
| Mean age (±SD), (range) | 34 years (±9.5), (18–64) | 43 years (±6.3), (27–53) | 0.0008 |
| Mean anti-Chlamydia IgG AU/ml, (range) £ | 11.8 (4–38) | 60.4 (19–86) | <0.001 |
| Presence of coinfections † % (n) | 47.3% (45) | 92.3% (12) | 0.0023 |
| HIV % (n) | 10.5% (10) | 69.2% (9) | <0.001 |
| Syphilis % (n) | 16.8% (16) | 69.2% (9) | <0.001 |
| Gonorrhoea* % (n) | 17.8% (17) | 23.0% (3) | 0.6519 |
| Non-L serovar CT* % (n) | 13.7% (13) | 0% (0) | 0.155 |
| HBV % (n) | 3.2% (3) | 30.8% (4) | 0.001 |
| HCV % (n) | 1.1% (1) | 7.7% (1) | 0.570 |
| HPV warts % (n) | 10.5% (10) | 30.8% (4) | 0.110 |
